“The Indian pharmaceutical industry is at the center stage in the global pharmaceutical arena and Rekvina is at the forefront in delivering the India centric advantages to the advanced and developing countries of the world. From a small domestic company at inception in middle of 80’s, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of twenty crore INR.

It is with the unwavering 'dedication' and the 'Will to Win ' of Team Rekvina across India that we have traversed this journey so far.

We are committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs. We are confident that our efforts would see the Company grow from strength to strength in the global space in the years to come. Whilst we continue to enhance the momentum of our products, we are also accelerating our drug discovery program through collaborations and alliances.

As we move ahead we are determined to capitalize on the new opportunities based on our strong fundamentals of innovation, entrepreneurship and aggressive marketing. We remain committed to actively pursue our strategy of growth through organic and inorganic means.

Today, we are well prepared to be amongst the top 100 pharmaceutical companies of India and attain a size of 100 crore INR by 2020. As we step into the next phase, we are driven by our ambition, willing to invest in the growth of our people and business, marching towards the new horizon of global leadership."

Mr. Mukesh Shah
Chairman & Managing Director

This company has introduced the concept of Dispersible Kid Tablets for Pediatric patients. Our unique formulations include our prestigious product “REKFA”, (Essential Fatty Acid - in Capsule, Cream & Pediatric Drop). Enthused by the market response, the group introduced many more specialised quality products for Human Health Care. We have introduced highly specialized products for Gynecological specialty and finally introduced our prestigious product REKSEAL (Enbucrilate – n-Butylcyanoacrylate), the Tissue Adhesive which has further added a feather of success in our cap and lead to the introduction of still more specialised products.
Vision Rekvina

To emerge as a global Pharma player. To enter the advanced markets of the world with a sustained presence over the long-term.
arow Planning proactively to introduce the right products at the right time with the support of WHO-GMP and other quality certifications.
arow Introducing products in the gynecological disorders and surgical therapeutic segments.
arow Entering advanced markets with New Chemical Entities (NCE).
arow Maintaining the highest standards of current Good Manufacturing Practices (cGMP / Revised Schedule-M).
arow Delivering customer value through a high quality of technical support, analytical data, technical documentation and regulatory compliance.
arow Generating a cost advantage for its customers and the company through process innovation of raw material efficiency, innovative R&D and engineering.
arow Making operations safe and reliable by minimizing waste, implementing effective waste treatment and protecting the environment.

Mission Rekvina

arow While committing to an on-going improvement in performance revolving around effective customer management, we maintain:
arow The highest levels of integrity in business conduct,
arow A strong sense of public responsibility.
arow We promote and provide an open and participative work environment with growth opportunities for all employees.


Rekvina Laboratories has all the plans to come out with many sophisticated formulations and life saving medicines.

To spread our wings all over India in domestic market and also to expand our activities in Eastern Asia, Europe, African continental as well as Middle East countries.

To establish a Research and Development Department with all kind of technical advancement.

To have a chain of company's retail medical outlets in all the metros in India, which will remain open 24 hrs a day.